How much better are updated COVID boosters? Pfizer announces first results in human clinical trial - CBS News
Mixed vaccine schedules offer strong booster responses after two doses of CoronaVac vaccine CORONAVIRUSVACCINES — Target Discovery Institute
First results of proton injection commissioning of the AGS Booster synchrotron - UNT Digital Library
COVID-19 Booster Shots: What to Know About the Safety and Side Effects
FDA vaccine advisers 'disappointed' and 'angry' that early data about new Covid-19 booster shot wasn't presented for review last year | CNN
What do people think about COVID-19 booster doses?, CCDR 48(7/8) - Canada.ca
Effectiveness of a second BNT162b2 booster vaccine against hospitalization and death from COVID-19 in adults aged over 60 years | Nature Medicine
Protection following BNT162b2 booster in adolescents substantially exceeds that of a fresh 2-dose vaccine | Nature Communications
Boosters Work | CDC
Protein-based SARS-CoV-2 spike vaccine booster increases cross-neutralization against SARS-CoV-2 variants of concern in non-human primates | Nature Communications
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 | MMWR
Effectiveness of a second BNT162b2 booster vaccine against hospitalization and death from COVID-19 in adults aged over 60 years | Nature Medicine
F.D.A. Authorizes Updated Covid Booster Shots Targeting Omicron Subvariants - The New York Times
Antibody persistence 2 and 3 years after booster vaccination of adolescents with recombinant acellular pertussis monovalent aPgen or combined TdaPgen vaccines - eClinicalMedicine
BNT162b2 Vaccine Booster and Mortality Due to Covid-19 | NEJM
COVID-19 Update: Bivalent Pfizer and Moderna COVID-19 Vaccines for Booster Immunization | The Medical Letter Inc.
Safety and immunogenicity of seven COVID-19 vaccines as a third dose ( booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial -
COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study - The Lancet Infectious Diseases
A Bivalent Omicron-Containing Booster Vaccine against Covid-19 | NEJM
NH COVID-19 Healthcare Provider and Public Health Partner Call
Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine | NEJM
Fall COVID Booster Campaign Save Thousands Lives, Billions Dollars | Commonwealth Fund
